Discharge Prescription Errors After the Implementation of a Prospective Pharmacist Review Process in a Pediatric

Erin N Waehner1, Stephanie Weightman1, Debora Castañeda1

  • 1From the Department of Pharmacy, Children's Health.

Pediatric Emergency Care
|September 2, 2020
PubMed

Insights

A pharmacist review of pediatric emergency department discharge prescriptions identified a 5.5% error rate, with most errors being minor and not leading to patient harm.

Area of Science:

  • Pediatric Emergency Medicine
  • Pharmacology
  • Patient Safety

Background:

  • Pediatric patients in emergency departments face higher risks of medication errors.
  • Pharmacist interventions reduce inpatient medication errors, but less is known about their impact on discharge prescriptions.

Purpose of the Study:

  • To identify and describe prescription errors in pediatric emergency department discharge prescriptions after implementing a pharmacist verification process.

Main Methods:

  • A retrospective chart review of 750 randomly selected discharge prescriptions from January 1, 2016, to June 30, 2016.
  • Independent review by two pharmacists, with a third resolving discrepancies.
  • Error classification and severity assessment using the Taylor et al 2005 scale.

Main Results:

  • A total of 41 errors were found in 750 prescriptions, yielding an error rate of 5.5%.
  • The most frequent error types were missing prescription duration (39%) and issues with antimicrobial optimization (24.4%).
  • No errors were classified as severe or serious, and no patient harm was reported.

Conclusions:

  • The prospective pharmacist verification process identified a low rate of minor medication errors in pediatric emergency department discharge prescriptions.
  • Further research could explore strategies to further minimize these errors and their potential impact.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
172
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
148
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
1.2K